Cargando…
2527. Impact of Hypoalbuminemia on Clinical Outcomes Among Patients with Obesity Treated with Ceftriaxone
BACKGROUND: Due to extensive protein binding, use of ceftriaxone in the setting of hypoalbuminemia may result in suboptimal drug exposure via higher concentrations of unbound drug resulting in increased volume of distribution and increased drug clearance. We aimed to evaluate the impact of hypoalbum...
Autores principales: | Rivera (O'Connor), Christina G, Abu Saleh, Omar M, McHugh, Jack W, Draper, Evan, Mara, Kristin, Hannan, Kellie Arensman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678609/ http://dx.doi.org/10.1093/ofid/ofad500.2145 |
Ejemplares similares
-
1839. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia
por: Steere, Evan, et al.
Publicado: (2022) -
Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia: A Propensity-Matched, Retrospective Cohort Study
por: Steere, Evan L, et al.
Publicado: (2023) -
A Report on 2527 Cases of Primary Suture
Publicado: (1918) -
Comparative renal risk of long-term use of beta-lactams in combination with vancomycin across the continuum of care
por: Dolly, Lauren M., et al.
Publicado: (2023) -
2527: Citation network towards faculty development inside and outside of CTSAs
por: Abiola, Solomon, et al.
Publicado: (2018)